DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues

DAS181 is a novel candidate therapeutic agent against influenza virus which functions via the mechanism of removing the virus receptor, sialic acid (Sia), from the adjacent glycan structures. DAS181 and its analogues have previously been shown to be potently active against multiple strains of season...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chan, Renee W. Y., Chan, Michael C. W., Wong, Adam C. N., Karamanska, Rositsa, Dell, Anne, Haslam, Stuart M., Sihoe, Alan D. L., Chui, W. H., Triana-Baltzer, Gallen, Li, Qixiang, Peiris, J. S. Malik, Fang, Fang, Nicholls, John M.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2009
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2737896/
https://ncbi.nlm.nih.gov/pubmed/19596886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00389-09
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires